RCT Comparing Conventional Haemorrhoidectomy With Laser Haemorrhoidoplasty
Launched by SENGKANG GENERAL HOSPITAL · Mar 29, 2020
Trial Information
Current as of April 29, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is comparing two different treatments for hemorrhoids, which are swollen blood vessels in the rectal area that can cause pain and bleeding. The two methods being studied are the traditional surgical procedure called conventional open haemorrhoidectomy (COH) and a newer method known as laser haemorrhoidoplasty (LAH). The goal is to see which procedure results in less pain and fewer complications after surgery. This trial is particularly looking at patients who have significant symptoms from their hemorrhoids.
To participate in this study, individuals must be between 21 and 90 years old, have symptoms from hemorrhoids, and have never had hemorrhoid surgery before. Participants will undergo one of the two procedures and will be asked to complete some questionnaires about their recovery and any symptoms they experience over the next year. This study is important because it aims to find a treatment that could make recovery easier for patients with hemorrhoids, helping to reduce their discomfort and improve their quality of life.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. between 21-90 years old
- • 2. presents with symptomatic haemorrhoids as evident from clinical assessment
- • 3. never had any haemorrhoid-related operations performed on them before
- • 4. fit for general anaesthesia
- • 5. able to give informed consent
- • 6. willing to be randomized
- • 7. willing to fill in post-operative questionnaires and be compliant to follow up
- Exclusion Criteria:
- • 1. Are pregnant
- • 2. Are prisoners
- • 3. Intellectually, mentally or emotionally deemed not able to provide an informed consent and/or are unable to fill up the post-procedure questionnaires/VAS score
- • 4. Have had previous haemorrhoid procedural treatment before (except Rubber Band Ligation)
- • 5. Declined endoscopic evaluation
- • 6. Are on anti-coagulation
- • 7. Have history of thrombophilia
- • 8. Are on steroids
- • 9. Have haemorrhoids which are incidentally found on endoscopy/clinical examination but are asymptomatic from it
About Sengkang General Hospital
Sengkang General Hospital (SKGH) is a leading healthcare institution in Singapore, dedicated to providing comprehensive medical services and advancing clinical research to enhance patient care. As a key player in the region's healthcare landscape, SKGH is committed to fostering innovation through clinical trials that explore new therapies and treatments. The hospital is equipped with state-of-the-art facilities and a multidisciplinary team of experienced healthcare professionals, ensuring a robust environment for conducting high-quality research. By prioritizing ethical standards and patient safety, Sengkang General Hospital aims to contribute significantly to the global medical community and improve health outcomes for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Singapore, , Singapore
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials